Narvalus Srl is Pleased to Announce the Launch of the “T2 Target Transfector”

Thursday, 28 Sep 2006 · Biotechnology

A new technology for transfecting adherent cells on microchip. (PRWeb Sep 28, 2006) Read More »

Also:

	Vitalea Science Expands its Scientific Advisory Board, Expands Microdosing to Environmental Fate and Metabolism of Agricultural and Industrial Chemicals
	Technology Transfer Firm Partners with Local Alternative Energy Venture to Speed Commercialization: Innovation Management Partners, LLC Invests in Cleveland-based CleanFlo Technologies, LLC to Accelerate Technology Commercialization in the Growth Market for Alternative Fuels
	The AEgis Technologies Group Announces the Release of the Microsoft Excel Add-in for acslXtreme
	Monebo Technologies Obtains FDA Clearance to Market the CardioBelt™ Wireless ECG System
	Five Japanese Pharmaceutical Companies License Ariadne Pathway Studio Enterprise
	Alaska's Natural/Wild Food, Beverage and Bio Products Join Together to Stage Marketplace for Restaurant, Grocery and Food Service Market Buyers
	Akaza Research, SemanticBits and Robert H. Lurie Comprehensive Cancer Center of Northwestern University Partner to Develop caBIG™ Clinical Trials Adverse Events Reporting System for NIH's National Cancer Institute
	Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
	Vitalea Science Announces Key Addition to its Scientific Advisory Board in Microdosing for Pediatric Pharmacology and HIV Research
	Arrowhead Publishers' New Study Reveals Trends in Pharmaceutical Clinical Trial Outsourcing to Emerging Markets